Gabriele Calizzani

800 total citations
27 papers, 571 citations indexed

About

Gabriele Calizzani is a scholar working on Hematology, Management of Technology and Innovation and Molecular Biology. According to data from OpenAlex, Gabriele Calizzani has authored 27 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 4 papers in Management of Technology and Innovation and 3 papers in Molecular Biology. Recurrent topics in Gabriele Calizzani's work include Hemophilia Treatment and Research (16 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Platelet Disorders and Treatments (5 papers). Gabriele Calizzani is often cited by papers focused on Hemophilia Treatment and Research (16 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Platelet Disorders and Treatments (5 papers). Gabriele Calizzani collaborates with scholars based in Italy, United Kingdom and Armenia. Gabriele Calizzani's co-authors include Giuliano Grazzini, Fabio Candura, Simonetta Pupella, Kathelijn Fischer, Thierry Lambert, Liviana Catalano, Stefania Vaglio, Pier Mannuccio Mannucci, Giancarlo M Liumbruno and Michael Makris and has published in prestigious journals such as Thrombosis and Haemostasis, Thrombosis Research and Haemophilia.

In The Last Decade

Gabriele Calizzani

27 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriele Calizzani Italy 12 348 149 89 61 54 27 571
Christiane Gérard Belgium 12 127 0.4× 143 1.0× 31 0.3× 25 0.4× 19 0.4× 46 468
Dante Mário Langhi Brazil 12 218 0.6× 65 0.4× 69 0.8× 125 2.0× 26 0.5× 53 463
Marcie Riches United States 9 263 0.8× 211 1.4× 44 0.5× 28 0.5× 73 1.4× 43 555
J.‐J. Lefrère France 12 52 0.1× 143 1.0× 53 0.6× 39 0.6× 21 0.4× 23 425
Francesca Fioredda Italy 12 84 0.2× 70 0.5× 53 0.6× 16 0.3× 55 1.0× 27 579
Magdalena Łętowska Poland 11 137 0.4× 62 0.4× 23 0.3× 49 0.8× 26 0.5× 74 430
Miguel Ortín United Kingdom 10 256 0.7× 40 0.3× 63 0.7× 50 0.8× 12 0.2× 18 414
John A.J. Barbara United Kingdom 12 76 0.2× 115 0.8× 17 0.2× 20 0.3× 31 0.6× 38 381
Sigrun Einarsdottir Sweden 9 110 0.3× 160 1.1× 36 0.4× 31 0.5× 15 0.3× 22 438
F L Dulley Brazil 12 145 0.4× 107 0.7× 31 0.3× 22 0.4× 25 0.5× 16 556

Countries citing papers authored by Gabriele Calizzani

Since Specialization
Citations

This map shows the geographic impact of Gabriele Calizzani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Calizzani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Calizzani more than expected).

Fields of papers citing papers by Gabriele Calizzani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Calizzani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Calizzani. The network helps show where Gabriele Calizzani may publish in the future.

Co-authorship network of co-authors of Gabriele Calizzani

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriele Calizzani. A scholar is included among the top collaborators of Gabriele Calizzani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriele Calizzani. Gabriele Calizzani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marano, Giuseppe, Stefania Vaglio, Simonetta Pupella, et al.. (2015). Hepatitis E: an old infection with new implications.. PubMed. 13(1). 6–17. 32 indexed citations
2.
Iorio, Alfonso, Flora Peyvandi, Gabriele Calizzani, et al.. (2015). Inhibitor development in non-severe haemophilia across Europe. Thrombosis and Haemostasis. 114(10). 670–675. 15 indexed citations
3.
Peyvandi, Flora, Gabriele Calizzani, Alex Gatt, et al.. (2015). Inhibitor development in haemophilia according to concentrate. Thrombosis and Haemostasis. 113(5). 968–975. 89 indexed citations
4.
Giangrande, Paul, et al.. (2014). The European standards of Haemophilia Centres.. PubMed. 12 Suppl 3. s525–30. 24 indexed citations
5.
Marano, Giuseppe, Stefania Vaglio, Simonetta Pupella, et al.. (2014). Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.. PubMed. 13(2). 1–13. 50 indexed citations
6.
Calizzani, Gabriele, Fabio Candura, Romano Arcieri, et al.. (2014). The Italian institutional accreditation model for Haemophilia Centres.. PubMed. 12 Suppl 3. s510–4. 4 indexed citations
7.
Candura, Fabio, et al.. (2014). The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.. PubMed. 12 Suppl 3. s519–24. 3 indexed citations
8.
Makris, Michael, Gabriele Calizzani, Kathelijn Fischer, et al.. (2014). The European Haemophilia Network (EUHANET).. PubMed. 12 Suppl 3. s515–8. 20 indexed citations
9.
Arcieri, Romano, Angelo Claudio Molinari, Giuseppe Mazza, et al.. (2014). Uncovered needs in the management of inherited bleeding disorders in Italy.. PubMed. 12 Suppl 3. s563–6. 3 indexed citations
10.
Vaglio, Stefania, Gabriele Calizzani, Monica Lanzoni, et al.. (2013). The demand for human albumin in Italy.. PubMed. 11 Suppl 4. s26–32. 12 indexed citations
11.
Coppola, Antonio, Annarita Tagliaferri, Gabriele Calizzani, et al.. (2013). Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.. PubMed. 11 Suppl 4. s101–9. 3 indexed citations
12.
Calizzani, Gabriele, Fabio Candura, Monica Lanzoni, et al.. (2013). The demand for factor VIII and for factor IX and the toll fractionation product surplus management.. PubMed. 11 Suppl 4. s64–76. 5 indexed citations
13.
Calizzani, Gabriele, Stefania Vaglio, Fabio Candura, et al.. (2013). The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.. PubMed. 11 Suppl 4. s6–12. 4 indexed citations
14.
Arcieri, Romano, Angelo Claudio Molinari, Giuseppe Mazza, et al.. (2013). Present and future challenges in the treatment of haemophilia: the patient's perspective.. PubMed. 11 Suppl 4. s82–5. 3 indexed citations
15.
Franchini, Massimo, Giancarlo Maria Liumbruno, Monica Lanzoni, et al.. (2013). Clinical use and the Italian demand for prothrombin complex concentrates.. PubMed. 11 Suppl 4. s94–100. 4 indexed citations
16.
Lanzoni, Monica, et al.. (2013). Public expenditure for plasma-derived and recombinant medicinal products in Italy.. PubMed. 11 Suppl 4. s110–7. 4 indexed citations
17.
Calizzani, Gabriele, Fabio Candura, Monica Lanzoni, et al.. (2013). Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.. PubMed. 11 Suppl 4. s118–31. 6 indexed citations
18.
Liumbruno, Giancarlo M, Massimo Franchini, Monica Lanzoni, et al.. (2013). Clinical use and the Italian demand for antithrombin.. PubMed. 11 Suppl 4. s86–93. 4 indexed citations
19.
Makris, Michael, Gabriele Calizzani, Kathelijn Fischer, et al.. (2010). EUHASS: The European Haemophilia Safety Surveillance system. Thrombosis Research. 127. S22–S25. 69 indexed citations
20.
Liumbruno, Giancarlo M, Kyriakoula Petropulacos, Andrea Mattivi, et al.. (2008). The Chikungunya epidemic in Italy and its repercussion on the blood system.. PubMed. 6(4). 199–210. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Gérard Breakdown of academic impact, for papers by Dante Mário Langhi Breakdown of academic impact, for papers by Marcie Riches Breakdown of academic impact, for papers by J.‐J. Lefrère Breakdown of academic impact, for papers by Francesca Fioredda Breakdown of academic impact, for papers by Magdalena Łętowska Breakdown of academic impact, for papers by Miguel Ortín Breakdown of academic impact, for papers by John A.J. Barbara Breakdown of academic impact, for papers by Sigrun Einarsdottir Breakdown of academic impact, for papers by F L Dulley
Rankless by CCL
2026